PRAVASTATIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pravastatin, and what generic alternatives are available?
Pravastatin is a drug marketed by Accord Hlthcare, Apnar Pharma Lp, Apotex, Aurobindo Pharma, Aurobindo Pharma Usa, Biocon Pharma, Chartwell Rx, Cipla, Dr Reddys Labs Inc, Glenmark Pharms Ltd, Hisun Pharm Hangzhou, Pharmobedient, Pliva Hrvatska Doo, Ranbaxy Labs Ltd, Watson Labs, and Zydus Pharms Usa. and is included in eighteen NDAs.
The generic ingredient in PRAVASTATIN is pravastatin sodium. There are sixteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pravastatin
A generic version of PRAVASTATIN was approved as pravastatin sodium by AUROBINDO PHARMA USA on April 24th, 2006.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PRAVASTATIN?
- What are the global sales for PRAVASTATIN?
- What is Average Wholesale Price for PRAVASTATIN?
Summary for PRAVASTATIN
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 18 |
| Drug Prices: | Drug price information for PRAVASTATIN |
| Drug Sales Revenues: | Drug sales revenues for PRAVASTATIN |
| DailyMed Link: | PRAVASTATIN at DailyMed |
See drug prices for PRAVASTATIN
